Clinical Trial Update: Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating azacitidine for patients with resected pancreatic cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-07-22